G antigen 2A (GAGE2A) is a protein whose activity can be modulated by a number of specific biochemical mechanisms involving various signaling pathways. One such mechanism involves the direct stimulation of adenylyl cyclase, resulting in an increase in intracellular cyclic AMP (cAMP) concentration. The elevation of cAMP is a critical step, as it activates protein kinase A (PKA), which can phosphorylate GAGE2A, thereby enhancing its functional activity. Additionally, the activation of protein kinase C (PKC) through different agents can also contribute to the phosphorylation and activation of GAGE2A. PKC, being a versatile kinase, can target a range of proteins, and its role in the post-translational modification of GAGE2A could be significant in regulating GAGE2A's activity. Moreover, interventions that lead to increased intracellular calcium levels can activate calcium-dependent protein kinases, which have the potential to phosphorylate GAGE2A, suggesting a role for calcium signaling in the modulation of GAGE2A activity.
Further mechanisms include the use of a beta-adrenergic agonist that raises cAMP levels, indirectly leading to PKA activation and potential phosphorylation of GAGE2A. The inhibition of phosphodiesterases, which prevents the degradation of cAMP, also results in sustained PKA activity and subsequent phosphorylation of GAGE2A. Another pathway involves the stress-activated protein kinases, such as JNK, which can activate GAGE2A through phosphorylation. Additionally, the inhibition of protein phosphatases leads to increased phosphorylation levels of proteins within the cell, potentially enhancing GAGE2A activity. Lastly, perturbations in PI3K/AKT signaling and disruptions to ion homeostasis, such as inhibition of Na+/K+-ATPase, can result inalterations in phosphorylation patterns that impact the activity state of GAGE2A. These alterations could facilitate the phosphorylation and activation of GAGE2A by various kinases that respond to changes in the cellular environment.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Directly stimulates adenylyl cyclase, increasing cyclic AMP (cAMP) levels within cells. Elevated cAMP enhances protein kinase A (PKA) activity, which can phosphorylate GAGE2A, leading to its increased activation. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate a variety of proteins. PKC-mediated phosphorylation may increase GAGE2A activity through post-translational modifications. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $76.00 $265.00 | 80 | |
Increases intracellular calcium levels, which can activate calcium-dependent protein kinases. These kinases could phosphorylate GAGE2A and enhance its activity. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $27.00 $37.00 | 5 | |
Beta-adrenergic agonist that increases intracellular cAMP levels, indirectly leading to activation of PKA. PKA can then mediate the phosphorylation and activation of GAGE2A. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $45.00 $130.00 $480.00 $4450.00 | 74 | |
Cell-permeable cAMP analog that directly activates PKA. Upon activation, PKA may phosphorylate and increase the activity of GAGE2A. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
Inhibits phosphodiesterases, thereby preventing the degradation of cAMP. Increased cAMP levels can enhance PKA activity, resulting in increased phosphorylation and activation of GAGE2A. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $54.00 $128.00 $199.00 $311.00 | 23 | |
Calcium ionophore that elevates intracellular calcium levels, indirectly leading to the activation of calcium-dependent kinases which may phosphorylate and activate GAGE2A. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Non-specific inhibitor of phosphodiesterases leading to increased cAMP levels, which can enhance PKA activity and the subsequent phosphorylation and activation of GAGE2A. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates stress-activated protein kinases, such as JNK, which could lead to the phosphorylation and increased activity of GAGE2A. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $285.00 $520.00 $1300.00 | 78 | |
Inhibits protein phosphatases 1 and 2A, leading to increased phosphorylation levels of cellular proteins, which could enhance the activity of GAGE2A. | ||||||